Cannabis: Clinical Trials

15 trials for Cannabis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed. 15 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 115Completed 15
Phase 21Completed 1

Follow Cannabis: new trials by email Literature Review of Cannabis trials Research Report on Cannabis

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Delta-8-THC vs. Delta-9-THC on Simulated Driving Performance
Delta-9-THC, Delta-8-THC, Placebo - Cannabis
Phase 1CompletedJohns Hopkins University302024-07-012026-07-20
A Study of Ingested Cannabidiol in Healthy Occasional Cannabis Users
cannabis 0 mg, placebo, Cannabis 20 mg,, Cannabis 50 mg - Cannabis
Phase 1 / Phase 2CompletedCentre hospitalier de l'Université de Montréal (CHUM)702022-07-222024-04-22
The Pharmacokinetics and Pharmacodynamics of a Single Acute Dose of a Hemp-derived Oral Product With a 1:1 Ratio of CBD:CBD-A
CBD 1mg/Kg, CBD 2mg/Kg, CBD 4mg/Kg - Cannabis
Phase 1CompletedJohns Hopkins University212022-03-072023-06-07
Therapeutic Response of Cannabidiol in Rheumatoid Arthritis
200mg Cannabidiol by capsules twice daily, 400mg Cannabidiol by capsules twice daily, Placebo capsules - Rheumatoid Arthritis, Cannabis
Phase 1CompletedUniversity of California, Los Angeles672021-10-052024-06-07
The Pharmacokinetics and Pharmacodynamics of Hemp-based Topical Cannabinoid Products
CBD, THC, Placebo - Cannabis, Drug Effect
Phase 1CompletedJohns Hopkins University472021-07-142023-03-10
The Effect of Cannabidiol on Lean Body Mass in Patients Receiving Chemotherapy
Cannabidiol - Lean Body Mass, Cannabis
Phase 1CompletedUniversity of Copenhagen322020-12-012023-07-24
Behavioral Pharmacology of Cannabis and Nicotine
Cannabis, Nicotine - Cannabis, Nicotine
Phase 1CompletedJohns Hopkins University262020-09-152024-04-17
A Study Investigating the Bioavailability of CBD and THC in an Emulsion Product in a Healthy Population
Cannabis Preparation - Healthy, Cannabis
Phase 1CompletedNew Age Ventures LLC322020-06-192021-03-03
THC and Ketamine Effects in Humans: Relation to Neural Oscillations and Psychosis
Active Delta-9-THC, Placebo Delta-9-THC, Active Ketamine - Cannabis, Ketamine
Phase 1CompletedYale University222019-09-242024-03-25
Marijuana Effects on Simulated Driving Performance
Marijuana, Alcohol, placebo alcohol - Cannabis, Cannabis Use
Phase 1CompletedShanna Babalonis, PhD102019-07-012024-07-31
Laboratory Smoking of Marijuana "Blunts"
Marijuana - Cannabis
Phase 1CompletedBattelle Memorial Institute82019-04-102019-10-02
Pharmacokinetic and Pharmacodynamic Effects of Smoked and Vaporized Cannabis
Cannabis - Cannabis
Phase 1CompletedJohns Hopkins University182016-06-162019-09-13
Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabis
Oral cannabis - Cannabis
Phase 1CompletedJohns Hopkins University242014-06-012018-09-17
Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain Activation
Sativex(Registered Trademark), THC - Cannabis, Dependence
Phase 1CompletedNational Institute on Drug Abuse (NIDA)1082007-05-082017-07-02
Antagonist-Elicited Cannabis Withdrawal
THC, Rimonobant, Rimonabant - Cannabis, Dependence
Phase 1CompletedNational Institute on Drug Abuse (NIDA)2006-04-162017-07-02

Narrower conditions

Marijuana Abuse (15)  ·  Alcohol Drinking (1)  ·  Appetitive Behavior (1)  ·  Arthritis, Rheumatoid (1)  ·  Cachexia (1)  ·  Dysgeusia (1)  ·  Nausea (1)  ·  Neoplasms (1)  ·  Vomiting (1)

Broader conditions

Chemically-Induced Disorders (15)  ·  Mental Disorders (15)  ·  Substance-Related Disorders (15)  ·  Behavior (2)  ·  Arthritis (1)  ·  Autoimmune Diseases (1)  ·  Behavior, Animal (1)  ·  Body Weight (1)  ·  Body Weight Changes (1)  ·  Connective Tissue Diseases (1)  ·  Drinking Behavior (1)  ·  Immune System Diseases (1)  ·  Joint Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)

Interventions

nabiximols (7)  ·  Dronabinol (4)  ·  Cannabidiol (1)  ·  Ethanol (1)  ·  Exercise (1)  ·  Nicotine (1)  ·  Rimonabant (1)  ·  delta-8-tetrahydrocannabinol (1)

Sponsors

Johns Hopkins University (6)  ·  National Institute on Drug Abuse (NIDA) (2)  ·  Battelle Memorial Institute (1)  ·  Centre hospitalier de l'Université de Montréal (CHUM) (1)  ·  New Age Ventures LLC (1)  ·  Shanna Babalonis, PhD (1)  ·  University of California, Los Angeles (1)  ·  University of Copenhagen (1)  ·  Yale University (1)

Countries

United States (12)  ·  Canada (2)  ·  Denmark (1)

Top investigators

Ryan Vandrey, PhD (3)  ·  Tory Spindle, PhD (2)  ·  David Crowley, MD (1)  ·  Didier Jutras-Aswad, MD,MS (1)  ·  Jens Rikardt Andersen, MD (1)  ·  Rajiv Radhakrishnan, M.D. (1)  ·  Ryan Vandrey (1)  ·  Sebastian W Nielsen, MD (1)  ·  Veena Ranganath, MD, MS (1)  ·  Wallace B Pickworth, PhD (1)  ·  Ziva Cooper, PhD (1)

Results publications

PMID 21869692, PMID 30646391, PMID 35787693, PMID 40040421, PMID 41514385, PMID 42454450

NIH funding

R21DA044377 (1), R21DA045101 (1)